The Catalytic Activity and Micro‐Mechanisms of Reducible Metal Oxide Nanozymes in Relation to Their Antibacterial Efficacy
Small · 2026
DOI: 10.1002/smll.202514882 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, 2026. Verfasst von Melanie J Coathup und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biionix Cluster, College of Medicine, University of Central Florida, Orlando, Florida, United States. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Oxides, Metals, Nanostructures. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 551 Literaturangaben. Gefördert von: National Supercomputing Services via our membership of the UK HEC Materials Chemistry Consortium, National Science Foundation (NSF) Major Research Instrumentation (MRI) Program.
Abstract (Originalsprache)
Precision‐driven nanomaterial approaches continue to show enormous promise and are forecast to transform contemporary medicine. The core strength lies in the ability to engineer materials at the nanoscale to achieve unique physicochemical properties. A theory that is paramount to its unlimited future promise is in creating “designer” or “intelligent” nanomaterials precisely crafted to enable specific biological interactions for applications in health, disease, and infection. Fuelled by their ease of synthesis, catalytic nature, complex surface character, and tunability, the development of next‐generation reducible metal oxide nanozymes (rNZs) that mimic the complex perceptive and adaptive capabilities of natural enzymes is a topic of remarkable curiosity. In pursuit of decoding rNZ catalytic mechanisms, this review spotlights the critical contribution of atomistic features. The promise of rNZs to circumvent the therapeutic insufficiencies surrounding bacterial antimicrobial resistance is confirmed to be a viable route forward, and the first evidence of the use of ionizing radiation to augment activity is presented as a novel antibacterial strategy. In some respects, the micromechanisms remain cryptic and elusive. The data reveal the critical contribution of crystal facets and oxygen vacancies within an orchestrated, heterogeneous, tunable, but strikingly complex system. Deciphering these sophisticated behaviors is arguably the next frontier in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biionix Cluster, College of Medicine, University of Central Florida, Orlando, Florida, United States.
- Department of Physical and Life Sciences, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
- Advanced Materials Processing and Analysis Centre, Nanoscience Technology Center (NSTC), Department of Materials Science and Engineering, University of Central Florida, Orlando, Florida, United States.
- Department of Orthopedic Surgery, Baylor College of Medicine, Houston, Texas, United States.
ORCID-Profile: Melanie J Coathup, Sudipta Seal
Förderung
- National Supercomputing Services via our membership of the UK HEC Materials Chemistry Consortium
- National Science Foundation (NSF) Major Research Instrumentation (MRI) Program
Zitieren
APA
Coathup, M. J., Pugazhendhi, A. S., Brown, D., Neal, C. J., Ta, K. M., Kolanthai, E., Dhungana, B., Schwartzman, J. D., Molinari, M., & Seal, S. (2026). The Catalytic Activity and Micro‐Mechanisms of Reducible Metal Oxide Nanozymes in Relation to Their Antibacterial Efficacy. Small. https://doi.org/10.1002/smll.202514882
Vancouver
Coathup MJ, Pugazhendhi AS, Brown D, Neal CJ, Ta KM, Kolanthai E, et al. The Catalytic Activity and Micro‐Mechanisms of Reducible Metal Oxide Nanozymes in Relation to Their Antibacterial Efficacy. Small. 2026. doi:10.1002/smll.202514882
BibTeX
@article{Coathup2026,
author = {Coathup, Melanie J and Pugazhendhi, Abinaya Sindu and Brown, Daniel and Neal, Craig J and Ta, Khoa Minh and Kolanthai, Elayaraja and Dhungana, Bijay and Schwartzman, Jonathan D and Molinari, Marco and Seal, Sudipta},
title = {The Catalytic Activity and Micro‐Mechanisms of Reducible Metal Oxide Nanozymes in Relation to Their Antibacterial Efficacy},
journal = {Small},
year = {2026},
doi = {10.1002/smll.202514882}
}
EUVIMED